Lv1
78 积分 2022-05-19 加入
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
1个月前
已完结
Investigation of the Binding Determinants of Phosphopeptides Targeted to the Src Homology 2 Domain of the Signal Transducer and Activator of Transcription 3. Development of a High-Affinity Peptide Inhibitor
1个月前
已完结
Antibody-drug conjugates in colorectal cancer: advances, challenges, and prospectives
1个月前
已完结
trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification
2个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
2个月前
已完结
Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity
3个月前
已完结
A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects
3个月前
已完结
Disitamab Vedotin: First Approval
4个月前
已完结
Preclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE
5个月前
已完结
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
6个月前
已完结
皖公网安备34019202002308
